Elanco Animal Health Inc
NYSE:ELAN

Watchlist Manager
Elanco Animal Health Inc Logo
Elanco Animal Health Inc
NYSE:ELAN
Watchlist
Price: 9.46 USD Market Closed
Market Cap: 4.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ELAN Price Targets Summary
Elanco Animal Health Inc

Wall Street analysts forecast ELAN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELAN is 14.48 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.

ELAN Lowest Forecast
Wall Street Target
10.1 USD
7% Upside
ELAN Average Forecast
Wall Street Target
14.48 USD
53% Upside
ELAN Highest Forecast
Wall Street Target
18.9 USD
100% Upside
Lowest
Price Target
10.1 USD
7% Upside
Average
Price Target
14.48 USD
53% Upside
Highest
Price Target
18.9 USD
100% Upside
Elanco Animal Health Inc Competitors:
Price Targets
000423
Dong-E-E-Jiao Co Ltd
28% Upside
AMIORG
Ami Organics Ltd
136% Upside
S
688506
Sichuan Biokin Pharmaceutical Co Ltd
12% Upside
E
ENZY
Enzymatica AB (publ)
13% Upside
000423
Dong-E-E-Jiao Co Ltd
28% Upside
AMIORG
Ami Organics Ltd
136% Upside
S
688506
Sichuan Biokin Pharmaceutical Co Ltd
12% Upside
E
ENZY
Enzymatica AB (publ)
13% Upside
M
MBX
MBX Biosciences Inc
316% Upside
STAR
Strides Pharma Science Ltd
124% Upside
ALM
Almirall SA
32% Upside

Revenue
Forecast

Revenue Estimate
Elanco Animal Health Inc

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's revenue is 5%. The projected CAGR for the next 3 years is 4%.

5%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Elanco Animal Health Inc

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's operating income is -1%. The projected CAGR for the next 3 years is 50%.

-1%
Past Growth
50%
Estimated Growth
Estimates Accuracy
-57%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Elanco Animal Health Inc

The compound annual growth rate of Elanco Animal Health Inc's net income for the next 3 years is 18%.

N/A
Past Growth
18%
Estimated Growth
Estimates Accuracy
-85%
Average Miss
What are analyst estimates?

See Also

Summary
ELAN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ELAN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ELAN stock valuation using valuation multiples.
Wall Street Estimates
ELAN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ELAN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELAN's stock price target?
Price Target
14.48 USD

According to Wall Street analysts, the average 1-year price target for ELAN is 14.48 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.

What is Elanco Animal Health Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's revenue is 5%. The projected CAGR for the next 3 years is 4%.

What is Elanco Animal Health Inc's Operating Income forecast?
Projected CAGR
50%

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's operating income is -1%. The projected CAGR for the next 3 years is 50%.

What is Elanco Animal Health Inc's Net Income forecast?
Projected CAGR
18%

The compound annual growth rate of Elanco Animal Health Inc's net income for the next 3 years is 18%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 248,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.